Organogenesis Holdings Inc (NASDAQ: ORGO) on Monday, soared 5.54% from the previous trading day, before settling in for the closing price of $3.07. Within the past 52 weeks, ORGO’s price has moved between $2.28 and $6.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 13.06% annually for the last half of the decade. The company achieved an average annual earnings per share of 754.67%. With a float of $64.14 million, this company’s outstanding shares have now reached $126.85 million.
In an organization with 869 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 74.89%, operating margin of -5.27%, and the pretax margin is -5.29%.
Organogenesis Holdings Inc (ORGO) Insider Updates
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Organogenesis Holdings Inc is 49.44%, while institutional ownership is 51.46%. The most recent insider transaction that took place on Jun 05 ’25, was worth 413,625. In this transaction Chief Admin. and Legal Officer of this company bought 142,379 shares at a rate of $2.91, taking the stock ownership to the 837,437 shares. Before that another transaction happened on Jun 04 ’25, when Company’s Chief Admin. and Legal Officer bought 100,863 for $2.82, making the entire transaction worth $284,716. This insider now owns 695,058 shares in total.
Organogenesis Holdings Inc (ORGO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 754.67% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Organogenesis Holdings Inc (ORGO) is currently performing well based on its current performance indicators. A quick ratio of 3.67 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach 0.20 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.8 million. That was inferior than the volume of 1.67 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 48.17%. Additionally, its Average True Range was 0.26.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 15.36%, which indicates a significant decrease from 57.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 78.22% in the past 14 days, which was lower than the 161.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.75, while its 200-day Moving Average is $3.60. However, in the short run, Organogenesis Holdings Inc’s stock first resistance to watch stands at $3.30. Second resistance stands at $3.37. The third major resistance level sits at $3.48. If the price goes on to break the first support level at $3.13, it is likely to go to the next support level at $3.02. Assuming the price breaks the second support level, the third support level stands at $2.95.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
Market capitalization of the company is 411.01 million based on 126,854K outstanding shares. Right now, sales total 482,040 K and income totals 860 K. The company made 86,690 K in profit during its latest quarter, and -18,840 K in sales during its previous quarter.
